Coinbase CEO-Backed NewLimit Claims Aging Reversal Breakthrough, Raises $435 Million For Human Trials

Stocks Yahoo Finance By Yahoo Finance 04 Jun 2026 18:31 1 min read

Coinbase CEO-Backed NewLimit Claims Aging Reversal Breakthrough, Raises $435 Million For Human Trials

Coinbase CEO-Backed NewLimit Claims Aging Reversal Breakthrough, Raises $435 Million For Human Trials

Coinbase CEO-Backed NewLimit Claims Aging Reversal Breakthrough, Raises $435 Million For Human Trials

Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.